iBio's GAAP loss for 3M 2022 fiscal year was $8.94 million, up 18.7% from $7.534 million in the prior year. Revenue declined 48.5% to $211,000 from $410,000 a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept